Andrew
01-06-04, 08:08 PM
Forest Laboratories' selective serotonin reuptake inhibitor Lexapro has been approved for the treatment of generalized anxiety disorder, according to the company. The antidepressant (escitalopram oxalate) has already received FDA approval for major depressive disorder.